Inspection Record

Piramal Healthcare (Canada) Limited — Health Canada Inspection Findings

Health CanadaInspected 2022-11-14 5 findingsMaterial and supplier controlDeviation, CAPA, and investigationLaboratory and QC controlsOther quality systemComplaint and recall handling

View the regulator's official source The source document is always the basis for judgement.

Findings

1Material and supplier control

The segregation, rotation of stock, and/or the transportation of raw materials, packaging materials, intermediates, bulk drugs, and/or finished products was inadequate. The premises were not designed, constructed, operated, and/or maintained to prevent contamination.

2Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

3Laboratory and QC controls

The creation, maintenance, processing, and/or review of laboratory data was inadequate.

4Other quality system

The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records.

5Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-11-14. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Piramal Healthcare (Canada) Limited company profile — full history Health Canada documents, 2022 Go to Findings search